title: Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.
authors: Gonzalo
authors: G
authors: Laje
authors: Níall
authors: N
authors: Lally
authors: Daniel
authors: D
authors: Mathews
authors: Nancy
authors: N
authors: Brutsche
authors: Anat
authors: A
authors: Chemerinski
authors: Nirmala
authors: N
authors: Akula
authors: Benjamin
authors: B
authors: Kelmendi
authors: Arthur
authors: A
authors: Simen
authors: Francis J
authors: FJ
authors: McMahon
authors: Gerard
authors: G
authors: Sanacora
authors: Carlos
authors: C
authors: Zarate
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D018592:Cross-Over Studies; D003866:Depressive Disorder / Q000188:drug therapy* / Q000235:genetics*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D007649:Ketamine